FDA Adcomms Are Back: Four Cancer Drugs, COVID-19 Vaccine Formulations To Get Reviews

 
• By Sue Sutter and Bridget Silverman
  
Meeting
The FDA will host three days of advisory committee meetings in mid-May. (Shutterstock)

More from US Advisory Committees

More from Vaccines